Inability to undergo neuroimaging with Magnetic Resonance
Clinically significant hepatic disease as demonstrated by history, clinical exam (ascites, varices), or laboratory findings (LFTs \>2x normal, coagulopathy as described)
Comorbid conditions likely to complicate therapy including but not limited to the following: a history of New York Heart Association class II, III, or IV Congestive Heart Failure; end-stage acquired immune deficiency syndrome
Pregnancy
Malignancy (history of or active)
Concomitant use with antineoplastic, immunosuppressive or immune modulating therapies